Œ¤‹†‚s‚n‚o
Œ¤‹†‹ĘŃ


==Œ¤‹†‹ĘŃi2006”Nj==
yŒ“’˜z
  1. Kawamura-Saito M, Yamazaki Y, Kaneko K, Kawaguchi N, Kanda H, Mukai H, Gotoh T, Motoi T,  Fukayama M, Aburatani H, Takizawa T, Nakamura T. Fusion between CIC and DUX4 up-regulates PEA3 family genes Ewing-like sarcomas with t(4;19) (q35;q13) translocation. Human Molecular Genetics. 15: 2125-2137, 2006.
  2. Georgieva GS, Kurata S, Ikeda S, Eishi Y, Mitaka C, Imai T. Nonischemic lung injury by mediators from unilateral ischemic reperfused lung: ameliorating effect of tumor necrosis factor-alpha-converting enzyme inhibitor. Shock. 27:84-90, 2007.
  3. Ohta K, Yokoyama T, Abe T, Kurakawa E, Park J, Izumi M, Eishi Y, Ohyashiki K, Setoguchi Y. Identification of propionibacterium acnes in a case with stage III pulmonary sarcoidosis involving hepatosplenic disease. Nihon Kokyuki Gakkai Zasshi. 44:625-630, 2006.
  4. Marubuchi S, Okuda T, Tagawa K, Enokido Y, Horiuchi D, Shimokawa R, Tamura T, Qi ML, Eishi Y, Watabe K, Shibata M, Nakagawa M, Okazawa H. Hepatoma-derived growth factor, a new trophic factor for motor neurons, is up-regulated in the spinal cord of PQBP-1 transgenic mice before onset of degeneration. J Neurochem. 99:70-83, 2006.
  5. Tanabe T, Ishige I, Suzuki Y, Aita Y, Furukawa A, Ishige Y, Uchida K, Suzuki T, Takemura T, Ikushima S, Oritsu M, Yokoyama T, Fujimoto Y, Fukase K, Inohara N, Nunez G, Eishi Y.  Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes. Biochim Biophys Acta. 1762:794-801, 2006.
  6. Fenocchi E, Martinez L, Tolve J, Montano D, Rondan M, Parra-Blanco A, Eishi Y. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev. 15:384-390, 2006.
  7. Georgieva GS, Kurata S, Ikeda S, Teng S, Katoh I, Eishi Y, Mitaka C, Imai T. Prevention of ischemia reperfusion injury by positive pulmonary venous pressure in isolated rat lung. Shock. 25:66-72, 2006.
  8. Ogawa J, Harigai M, Akashi T, Nagasaka K, Suzuki F, Tominaga S, Miyasaka N. Exacerbation of chronic active Epstein-Barr virus infection in a patient with rheumatoid arthritis receiving humanised anti-interleukin-6 receptor monoclonal antibody. Ann Rheum Dis. 65:1667-1669, 2006
  9. Minami I, Tateno T, Yoshimoto T, Doi M, Izumiyama H, Akashi T, Hirata Y. Subclinical Cushings disease with amelioration of metabolic comorbidities after removal of pituitary tumor. Intern Med. 45:1231-1235, 2006.
  10. Yamada I, Izumi Y, Kawano T, Yoshino N, Tetsumura A, Kumagai J, Shibuya H. Esophageal carcinoma: evaluation with high-resolution three-dimensional constructive interference in steady state MR imaging in vitro. J Magn Reson Imaging.  24:1326-1332, 2006.
  11. Kuramochi J, Arai T, Ikeda S, Kumagai J, Uetake H, Sugihara K. High Pin1 expression is associated with tumor progression in colorectal cancer. J Surg Oncol. 94:155-160, 2006.
  12. Yoshizaki T. Arai H. Igari T. Tabuchi N. Tanaka H. Sunamori M. Endoscopic radial artery harvesting: our initial experience and results of the first 25 patients. Journal Article] Annals of Thoracic & Cardiovascular Surgery. 11:391-396, 2005 .
  13. Sasajima K, Kudo SE, Inoue H, Takeuchi T, Kashida H, Hidaka E, Kawachi H, Sakashita M, Tanaka J, Shirokawa A. Real-time in vivo virtual histology of  colorectal lesions when using the endocytoscopy system.  Gastrointest Endosc. 63:1010-1017, 2006.
  14. ‘¾“cD, ‰”ŽR’q‰›, ˆ¢•”“N–ē, ŒÉģŒb—, –p’C_, ņ”ü‹M, ]Ī‹`M, ‘剮•~ˆź”n, £ŒĖŒū–õO. “÷‰čŽī“ą‚ÉP.acnes‹Ū‘̐¬•Ŗ‚š”F‚߁AŠĢ‘ŸEäB‘Ÿ•a•ς𔺂Į‚½”x–ģŒ^ƒTƒ‹ƒRƒCƒh[ƒVƒX. “ś–{ŒÄ‹zŠķŠw‰ļŽGŽ. 44:625-630, 2006.
  15. Žį—ŃŒ’“ń, ‘å’JrŽ÷, —LˆäŽ Ž÷, Šāˆä•®, –{‘½‘, –¾ĪI, ¬’r·—Y. Giant cell fibroblastoma‚Ģ1—į. “ś–{¬Ž™ŠO‰ČŠw‰ļŽGŽ. 42:258-262, 2006.
  16. Vˆär•¶, –å”n‹v”üŽq, ģ“cŒ¤˜Y, ‘¾“c³•ä, o]—m‰ī, “”Œ“ƒŽq, ]ģ’¼l, ‰Ķ“ą—m, ‘D“cMŒ°, ‹g“c‘€. H“¹‚É”­¶‚µ‚½pyogenic granuloma‚Ģ1—į. ˆŻ‚Ę’°. 41:983-989, 2006.
  17. ģ“cŒ¤˜Y, –å”n‹v”üŽq, ‰Ķ“ą—m, “”Œ“ƒŽq, ‘D“cMŒ°, ŒF’J—mˆź, ‹g“c‘€.yH“¹•\ŻŠą‚Ģ“ąŽ‹‹¾f’f@Å‹ß‚̐i•ązcontact endoscopy‚Ŗ‘ń‚­H“¹ƒˆ[ƒh•sõ‘Ń‚ĢŠÓ•Ź. ˆŻ‚Ę’°. 41:225-232, 2006.
  18. ‘¾“c‰p—¢Žq, ē“c‰ĄŽq, “y”ģ‚܂䂯, ށ‰Ęˆź’m, ˆä“c—², ˆĄ“”–«, ¬—Ń‘å•ć, LģŸśc, t“ś–Š, ²X–ؐ¬. ćč–储‚ę‚Ń‘¼‘ŸŠķ‚É‘½”­«“§ĶƒAƒ~ƒƒCƒhŽīįŽ‚š’ꂵ‚½ŒŒ‰t“§ĶгŽŅ‚Ģˆź–UŒŸ—į. “ś–{“§ĶˆćŠw‰ļŽGŽ. 39:1293-1297,2006.
  19. ’r“c‘, ¬—Ń‘å•ć. ”A×–Ef‚ɂ؂ƂéAlpha-methylacyl-CoA racemase(AMACR/P504S)‚Ģ—Ēˆ««ŠÓ•Ź‚ÉŠÖ‚·‚é—L—p«. Šą‚Ģ—Õ°. 52:295-299, 2006.
y’˜‘E‘ąz
  1. ‘źąV“oˆź˜YF–¢•Ŗ‰»Œ^ˆŻŠą‚š‚ß‚®‚Į‚ā@‚Q•a—Œ`‘ŌŠw‚©‚ē‚Ż‚½–¢•Ŗ‰»Œ^ˆŻŠą‚Ģ“Į’„@‡@”­¶Šw“I‚É•Ŗ‰»Œ^ˆŻŠą‚Ƃǂ±‚ŖˆŁ‚Č‚é‚Ģ‚©HTHE GI FOREFRONTA2F110-118A2006
  2. ]Ī‹`MF“ĮW@“÷‰čŽī«Ž¾Š³‚š‚ß‚®‚éÅ‹ß‚ĢƒgƒsƒbƒNƒXAƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ģ•aˆö‚š‚ß‚®‚Į‚āA•a—‚Ę—Õ°A24F18-27A2006
  3. ŒF’J“ń˜NAˆÉ“”’F‰ę‘œ‰šĶ‚É‚ę‚é‘gDf’fA•a—‚Ę—Õ°A24F387-391A2006
  4. ŒF’J“ń˜NA]Ī‹`MA¬’r·—YFŠw¶”ŒNA‚¢‚Ü•a—‚Ŗ‚Ø‚ą‚µ‚ė‚¢‚¼!@•a—ŠwŽ©ŽåŠwK‚ĢƒXƒXƒ@•a—Šw“I’mŽÆ‚š[‚ß‚é@•a—ƒAƒgƒ‰ƒX‚Ģģ¬A•a—‚Ę—Õ°A24:1207-1214A2006
  5. ‰Ķ“ą—mA¬’r·—Y(•Ŗ’SŽ·•M)F‘å’°ƒJƒ‹ƒ`ƒmƒCƒh‚Ø‚ę‚Ń“ą•Ŗ”å×–EŠą\‘ę62‰ń‘å’°ŠąŒ¤‹†‰ļƒAƒ“ƒP[ƒgŒ‹‰Ź‚𒆐S‚Ɂ@‘咰޾гNOW2006. pp179-185. “ś–{ƒƒfƒBƒJƒ‹ƒZƒ“ƒ^[. 2006.
  6. ‰Ķ“ą—mF¶ŒŸ•W–{‚̓ǂݕū@H“¹¶ŒŸ•W–{‚̓ǂݕū@‰~’Œć”ēE‘Bć”ē•a•ρAG.I.Research . 14:385-393, 2006.
  7. ‰Ķ“ą—mF¶ŒŸ•W–{‚̓ǂݕū@H“¹¶ŒŸ•W–{‚̓ǂݕū@G•½ć”ē•a•ρAG.I.Research. 14: 287-295, 2006.
yŠw‰ļEu‰‰‰ļz
  1. Yoshinobu Eishi (Guest speaker), Propionibacteria in the Etiology of Sarcoidosis, Autoimmunity Research Foundation: Conference at the LAX Hilton, LA, USA, June 18, 2006.
  2. Kawachi H, Seki T, Yuzawa M, Eishi Y, Takizawa T, Koike M  Histological evaluation of gtumor budding/sproutingh as predictive factor of lymph nodes metastasis in submucosal invasive colorectal cancer  The 10th Korea-Japan-China Colorectal Cancer Symposium. 2006”N9ŒŽCƒ\ƒEƒ‹
  3. ]Ī‹`Miµ‘Ņu‰‰juŠ“õĒŠw‚ĢBreak-Through‚š–ŚŽw‚µ‚āvŠ“õE–ʉuEƒAƒŒƒ‹ƒM[‚̐ړ_‚š‹‚ß‚ÄFŒÄ‹zŠķŠ“õĒ‚𒆐S‚ɁAƒTƒ‹ƒRƒCƒh[ƒVƒX‚ɂ؂ƂéPropionibacterium acnesA‘ę80‰ń“ś–{Š“õĒŠw‰ļŠwpu‰‰‰ļi2006”N4ŒŽ21“śAƒzƒeƒ‹“śq“Œ‹žj
  4. ]Ī‹`Miµ‘Ņu‰‰ju”Œć’–Ś‚³‚ź‚銓õĒvƒTƒ‹ƒRƒCƒh[ƒVƒX‚ĘPropionibacterium acnesA‘ę54‰ń“ś–{‰»Šw—Ć–@Šw‰ļ‘‰ļi2006”N5ŒŽ19“śA‘—§‹ž“s‘Ū‰ļŠŁj
  5. ]Ī‹`Miµ‘Ņu‰‰jƒTƒ‹ƒRƒCƒh[ƒVƒXœ‹Ū—Ć–@‚ĢŒ»ó‚Ę“W–]AP. acnesŒ“ˆöą‚ĢŠT—vA‘ę26‰ń“ś–{ƒTƒ‹ƒRƒCƒh[ƒVƒX/“÷‰čŽī«Ž¾Š³Šw‰ļ‘‰ļi2006”N10ŒŽ6“śA“Œ‹ž‚±‚Ü‚ĪƒGƒ~ƒi[ƒXj
  6. ]Ī‹`MiV•·ŒfŚjAƒTƒ‹ƒRƒCƒh[ƒVƒX‚ĢƒAƒNƒl‹ŪŒ“ˆöą‚š’ń„AV‚µ‚¢Ž¾•a”­¶‹@\‚ā—D‚ꂽޔ—Ɛ¬Ń‚Ŗ•ńAMedical Tribune Vol.39, No.47F18`19•Å(2006”N11ŒŽ23“ś)
  7. ]Ī‹`MiƒeƒŒƒr•ś‰fjAƒTƒ‹ƒRƒCƒh[ƒVƒXFÅIŒxI‚½‚Æ‚µ‚Ģ–{“–‚Ķ•|‚¢‰Ę’ė‚ĢˆćŠwA2006”N8ŒŽ22“ś•ś‰f
  8. ]Ī‹`MF“ąˆö«Š“õĒ‚Ę‚µ‚Ä‚ĢƒTƒ‹ƒRƒCƒh[ƒVƒX‚ĢŽ¾•a”­¶‹@\AŠ“õĒŠwŽGŽ80ŠŖ5† Page544
  9. ‰Ķ“ą—m, ‘źąV“oˆź˜Y@Œūo”S–Œć”ē“ąŠą‚Ö‚ĢƒAƒvƒ[ƒ`@H“¹,ˆō“Ŗ,Žq‹{”S–Œ‚Ƃ̔äŠrŒŸ“¢@H“¹ˆŁŒ`¬‚̐f’f‚ĘŽę‚čˆµ‚¢@‘ę95‰ń“ś–{•a—Šw‰ļ‘‰ļ@2006”N4ŒŽC“Œ‹ž
  10. ¬—ѐ^‹G, ‰Ķ“ą—m, ‘źąV“oˆź˜Y, “ą“c‰Ą‰ī, ŠÖŖ³Šģ, ŒF’J“ń˜N, Ŗ–{“N¶, ‘D“cMŒ°, ]Ī‹`M, ¬’r·—Y@Microdissection–@‚É‚ę‚éH“¹ć”ē“ą•a•Ļ‚Ģp53ˆā“`Žq‰šĶ@‘ę95‰ń“ś–{•a—Šw‰ļ‘‰ļ@2006”N4ŒŽC“Œ‹ž
  11. ˆÉ“”’, ‰Ķ“ą—m, ‘qŽm, ¬—ѐ^‹G, ŠÖŖ³Šģ, “ą“c‰Ą‰ī, ˜n‰ė‘å, –¾ĪI, ‰Pˆä—T, ‹gąV–õ”V, ]Ī‹`M, •‘ŗ–ÆŽq, ģŒ“õ, ‘źąV“oˆź˜Y, ¬’r·—Y@”x‰ŠĒ«‹UŽīᇂ̕a—‘gDŠw“IŒŸ“¢@‘ę95‰ń“ś–{•a—Šw‰ļ‘‰ļ@2006”N4ŒŽC“Œ‹ž
  12. ŠÖ‹Ms, ‰Ķ“ą—m, ˆÉ“”‰hģ, –xŒūTˆź˜Y, ‘D“cMŒ°, ‘źąV“oˆź˜Y@ˆŻ“ū“Ŗó‘BŠą‚̐Z‚Ø‚ę‚Ń–¬ŠĒNP‚ÉŠÖ—^‚·‚éˆöŽq‚ĢŒŸ“¢@‘ę95‰ń“ś–{•a—Šw‰ļ‘‰ļ@2006”N4ŒŽC“Œ‹ž
  13. –¾ĪIAˆĄ“”“oA]Ī‹`MA‘źąV“oˆź˜YA¬’r·—YA‹gąV–õ”VA•‘ŗ–ÆŽqF–«‰ß•q«‚Ķ”x‘Ÿ‰Š‚É”F‚ß‚ē‚ź‚éüˆŪ‰»‘ƒ‚Ģ—§‘ĢÄ\’z‘œ‚Ģ“Į’„A‘ę95‰ń“ś–{•a—Šw‰ļ‘‰ļA2006”N4ŒŽA“Œ‹ž
  14. ’†‘ŗ­GAˆÉ“ŒŠ±éAˆÉ“”‰hģAŠÖ‹MsA‘D“cMŒ°A]Ī‹`MA–kģ¹LA‘źąV“oˆź˜YA¬’r·—YF@ˆóŠĀ×–EŠą‚Ģ”S–Œ“ąŠĀ‹«‚É“K‰ž‚µ‚½”S‰tŒ`Žæ”­Œ»‚ÉŠÖ‚·‚錟“¢@‘ę95‰ń“ś–{•a—Šw‰ļ‘‰ļA2006”N4ŒŽA“Œ‹ž
  15. –{ŠŌ•×, ¬—ѐ^‹G, ‰Ķ“ą—m, ŠÖŖ³Šģ, “ą“c‰Ą‰ī, ]Ī‹`M, ‘źąV“oˆź˜Y, ¬’r·—Y@ƒ}ƒCƒNƒƒ_ƒCƒZƒNƒVƒ‡ƒ“–@‚É‚ę‚é,•a—•W–{‚©‚ē‚Ģp53ˆā“`Žq•ĻˆŁ‚Ģ‰šĶ@‘ę95‰ń“ś–{•a—Šw‰ļ‘‰ļ@2006”N4ŒŽC“Œ‹ž
  16. ‘å’ĖŒO, Ž›č•¶¶, ’Ė“c•q, •Š“ˆ—², ‰ŗ‘ŗ—TĶ, –k‰Y‘×, ¬‘qN°, ]Ī‹`MFSƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ę“Į”­«Šg’£Œ^S‹ŲĒ‚ĢŠÓ•Ź@‹¹•”CT‚ɂ؂ƂécŠuƒŠƒ“ƒpßŽī’Æ‚Ģf’f“IˆÓ‹`AƒTƒ‹ƒRƒCƒh[ƒVƒX/“÷‰čŽī«Ž¾Š³26ŠŖSuppl. Page36
  17. ŒĆģ‚ ‚·‚©, “ą“c‰Ą‰ī, Ī‰ŗˆč•v, Ī‰ŗ—R‹I, •‘ŗ–ÆŽq, ¬—ѓГN, “…’Cˆź˜Y, ]Ī‹`MFP.acnes•Ŗ—£Š”‚Ģˆā“`ŽqŒ^E•\Œ»Œ`Žæ‚ĘƒTƒ‹ƒRƒCƒh[ƒVƒX޾г“ĮˆŁ«AƒTƒ‹ƒRƒCƒh[ƒVƒX/“÷‰čŽī«Ž¾Š³26ŠŖSuppl. Page34(2006.10)
  18. “ą“c‰Ą‰ī(“Œ‹žˆć‰ČŽ•‰Č‘åŠw l‘Ģ•a—Šw), •‘ŗ–ÆŽq, GuzmanJ, TheegartenD, ŠÖŖ³Šģ, ˆĄ“”“o, ˆÉ“”’, CostabelU, ]Ī‹`MF‰¢BƒTƒ‹ƒRƒCƒh[ƒVƒXгŽŅŒŸ‘Ģ‚É‚Ø‚Æ‚éP.acnes‚̖Ɖu‘gDŠw“IŒŸo—¦‚ÉŠÖ‚·‚錟“¢AƒTƒ‹ƒRƒCƒh[ƒVƒX/“÷‰čŽī«Ž¾Š³26ŠŖSuppl. Page34(2006.10)
  19. —é–ŲD”ü, “c•Ӎ„, Ī‰ŗˆč•v, Ī‰ŗ—R‹I, ŒĆģ‚ ‚·‚©, “ą“c‰Ą‰ī, —é–Ų‚¬, •‘ŗ–ÆŽq, ¶“‡‘sˆź˜Y, Ü’Ć–ś, ]Ī‹`MFƒTƒ‹ƒRƒCƒh[ƒVƒX޾•a‘fˆö‚Ę‚µ‚Ä‚ĢNOD1ˆā“`Žq‘½Œ^‚Ę‚»‚Ģ‹@”\ˆŁķ‚ÉŠÖ‚·‚錟“¢AƒTƒ‹ƒRƒCƒh[ƒVƒX/“÷‰čŽī«Ž¾Š³26ŠŖSuppl. Page33(2006.10)
  20. •‰ŖT“ń˜Y, ]Ī‹`M, Ī‰ŗˆč•v, Ī’ƉpŠģ, Ā–ؐLŽq, ‘ŗćƒŽq, •‘ŗ–ÆŽq, ”’Ī~ˆź, Ä“”Ÿ, ¬’r·—YFMALTƒŠƒ“ƒpŽīf’f‚ɂ؂ƂéAPI2-MALT1ƒLƒƒ‰ˆā“`ŽqŒŸo‚Ģ—L—p«‚ÉŠÖ‚·‚錟“¢A“ś–{•a—Šw‰ļ‰ļŽ95ŠŖ1† Page388(2006.04)
  21. ŒĆģ‚ ‚·‚©, Ī‰ŗˆč•v, Ī‰ŗ—R‹I, “ą“c‰Ą‰ī, ‹v•Ū“c•ä, ]Ī‹`M, ¬’r·—YFƒTƒ‹ƒRƒCƒh[ƒVƒX•a•Ļ•”•Ŗ—£Š”P.acnes‚Ģˆā“`Žq‘½Œ^‚Ę•\Œ»Œ`Žæ‚̉šĶA“ś–{•a—Šw‰ļ‰ļŽ95ŠŖ1† Page282(2006.04)
  22. —é–ŲD”ü, “c•Ӎ„, Ī‰ŗˆč•v, ]Ī‹`M, ¶“‡‘sˆź˜Y, •‘ŗ–ÆŽq, ’†ąV‚³‚ā‚©, ¬’r·—YFƒTƒ‹ƒRƒCƒh[ƒVƒX޾•a‘fˆö‚Ę‚µ‚Ä‚ĢNOD1ˆā“`Žq‘½Œ^‰šĶ‚Ø‚ę‚Ń‚»‚Ģ‹@”\‚ÉŠÖ‚·‚錟“¢A“ś–{•a—Šw‰ļ‰ļŽ95ŠŖ1† Page282(2006.04)
  23. “ą“c‰Ą‰ī, ]Ī‹`M, •‘ŗ–ÆŽq, ŠÖŖ³Šģ, ˆĄ“”“o, CostabelUlrich, GuzmanJosune, TheegartenDirk, ¬’r·—YF‰¢BƒTƒ‹ƒRƒCƒh[ƒVƒXгŽŅŒŸ‘Ģ‚š—p‚¢‚½Œ“ˆö×‹Ū‚ÉŠÖ‚·‚é–ʉu‘gDŠw“IŒŸ“¢A“ś–{•a—Šw‰ļ‰ļŽ95ŠŖ1† Page211(2006.04)
  24. ]Ī‹`MF”Œć’–Ś‚³‚ź‚銓õĒ@ƒTƒCƒRƒh[ƒVƒX‚ĘPropionibacterium acnes A“ś–{‰»Šw—Ć–@Šw‰ļŽGŽ54ŠŖSuppl.A Page62(2006.04)
  25. ‰ŖčC, “ś–ģŒ“ē‘¬, Ä“”Ÿ, ŠC–ģ—œ—¢, “cŽē—Bˆź, •›“‡—ms, “nē³„‹B, “c’†—R—˜Žq, Š~“cŒõ•v, Ō’ĖéŽ”, œA]“¹ŗ, “c’†“¹—Y, ]Ī‹`MF”xƒTƒ‹ƒRƒCƒh[ƒVƒX‚ɍ‡•¹‚µ‚½‹×–E«S‹Ų‰Š‚Ģˆź–UŒŸ—įAzŠĀŠķ‰Č59ŠŖ3† Page308(2006.03)
  26. ]Ī‹`MFSŒŒŠĒ޾г‚Ę‰ŠĒ@SƒTƒ‹ƒRƒCƒh[ƒVƒX‚𒆐S‚Ɂ@ƒTƒ‹ƒRƒCƒh[ƒVƒX‚Ģ•aˆö˜_AzŠĀŠķ‰Č59ŠŖ3† Page298-299(2006.03)
  27. ]Ī‹`MFŠ“õE‰ŠĒEƒAƒŒƒ‹ƒM[‚̐ړ_‚š‹‚ß‚Ä@ŒÄ‹zŠķŠ“õĒ‚𒆐S‚Ɂ@“ąˆö«Š“õĒ‚Ę‚µ‚Ä‚ĢƒTƒ‹ƒRƒCƒh[ƒVƒX‚ĢŽ¾•a”­¶‹@\AŠ“õĒŠwŽGŽ80ŠŖ—Õ‘ Page83(2006.03)
  28. ŽÄ“cćāAč•”‰xŽq, –¾ĪI, ¬’r·—Y@Šī’ź–Œ•؎惉ƒ~ƒjƒ“‚Ģ”­Œ»‚Ŗ”xŽīį‡×–E‚Ģ‘B”\‚É—^‚¦‚é‰e‹æ@“ś–{•a—Šw‰ļ‰ļŽ(0300-9181)95ŠŖ1† Page387(2006.04)
  29. m‘½“Š•F, ‹{č‘א¬, ‰Pˆä—T, ŠŻ‰ėl, ‘å’J‹`•v, ˆéŠLi, –¾ĪI, ˆī£’¼•F, ŽO‘īCŽi, ‹gąV–õ”VF–«’¹Ž”•a‚ɂ؂ƂéFas-Fas ligand‚Ģ”­Œ»‚ĢŒŸ“¢A“ś–{ŒÄ‹zŠķŠw‰ļŽGŽ(1343-3490)44ŠŖ‘Š§ Page234(2006.06)
  30. ŠŻ‰ėl, ‹{č‘א¬, m‘½“Š•F, ‘å’J‹`•v, –¾ĪI, ˆī£’¼•F, ŽO‘īCŽi, ‹gąV–õ”VF–«’¹Ž”•a‚ɂ؂Ƃé‘gDƒpƒ^[ƒ“‚ĘTh1/2ƒPƒ‚ƒJƒCƒ“EƒŒƒZƒvƒ^[‚ĢŒŸ“¢A“ś–{ŒÄ‹zŠķŠw‰ļŽGŽ44ŠŖ‘Š§ Page179(2006.06)
  31. ‚‹“äĢ–Ų, ‹v•Ū•¶l, Žį—ŃŽu•äŽq, ‘å–ŲŠw, Š_‰Ō˜a•F, •{“N–ē, Vˆä•¶Žq, •Ÿ“c“N–ē, ŽO–Ų“O, ¬ŽR‚•q, “Œ“cC“ń, ‘ŗć’¼–¤, ŽO‰YC, ŽR–{_•½, –¾ĪIFŒĄ‹Ē«”牺ŽīįŽ‚É‚Ä”­Ē‚µ‚½Langerhans cell sarcoma‚Ģˆź—įA—Տ°ŒŒ‰t47ŠŖ5† Page409(2006.05)
  32. ‘qŽƒˆź, VˆäŒ’L, ŒF’J“ń˜N, A’|G”V, ’†‘ŗ³F, ™Œ“Œ’ˆźFApc(ƒ¢716)/Rag-2ƒ_ƒuƒ‹ƒmƒbƒNƒAƒEƒgƒ}ƒEƒXƒ‚ƒfƒ‹‚š—p‚¢‚½‘å’°Žīᇂ̔­¶Ei“W‚ĢŒŸ“¢D@‘ę107‰ń“ś–{ŠO‰ČŠw‰ļA2006”N3ŒŽ29“ś|31“śA“Œ‹žD
  33. ‹ą’n‰Ć‹v, ¼–{‘ģ, ŒF’J“ń˜N, ]Ī‹`M, ¬’r·—YF”]Œ“”­ˆ««ƒŠƒ“ƒpŽī‚ɂ؂ƂéCD44‹y‚ŃMMP-9‚Ģ”­Œ»‚ĢŒŸ“¢D‘ę95‰ń“ś–{•a—Šw‰ļA2006”N4ŒŽ30“ś|5ŒŽ2“śA“Œ‹ž
  34. •Ź•{³Žu, ‘åģ~, Ō”öM–¾, ŒF’J“ń˜N, ŽRŒū‹v”üŽq, ‹g‰Ŗ—²’m, –Ų‰ŗ~”ށFˆćŽ•ŠwƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‹³ˆēƒVƒXƒeƒ€‚š—˜—p‚µ‚½,“`““I’†‘ˆćŠw‚ÉŠī‚Ć‚¢‚½ˆć‰ČŒn‹³Ž‚Ģģ¬D‘ę37‰ń“ś–{ˆćŠw‹³ˆēŠw‰ļA2006”N7ŒŽ29“ś|30“śA“Ž—Ē
  35. “…’Cˆź˜Y, ŒF’J“ń˜N, ]Ī‹`M, ćŒ“•qŒh, ‘źąV“oˆź˜Y, ¬’r·—YF‘O—§‘BŠą‘gD‚ɂ؂Ƃé_Œo“ą•Ŗ”åŽīį‡×–E‚ĢoŒ»•p“x‚Ø‚ę‚яoŒ»”‚ÉŠÖ‚·‚é–ʉu‘gD‰»Šw“IŒŸ“¢D@‘ę65‰ń“ś–{ŠąŠw‰ļA2006”N9ŒŽ28“ś|30“śA‰”•lD
  36. p‘O‚ɐf’f‚µ‚½¬’°Ž‰–bŽī‚É‚ę‚é’°•ĀĒĒ‚Ģˆź—į(‰ļ‹c˜^)@‰Į“”‚°(“Œ‹ž–kŽŠ‰ļ•ŪŒÆ•a‰@ ŠO‰Č), Žń“”‰īL, ’†‘ŗ‹, ‹{č‘‹v, Z‰i‰Ą‹v, ¬¼•¶—Y, ’–Žė‹œ@“ś–{—Տ°ŠO‰ČŠw‰ļŽGŽ(1345-2843)67ŠŖ‘Š§ Page570(2006.10)@
  37. ‹}Œƒ‚Č—Õ°Œo‰ß‚š‚½‚Ē‚č”xƒ€ƒR[ƒ‹Ē‚ÅŽ€–S‚µ‚½œ‘Œ“”­HodgkinƒŠƒ“ƒpŽī‚Ģˆź—į(‰ļ‹c˜^)@‘å–ŲŠw(“Œ‹žˆć‰ČŽ•‰Č‘åŠw ˆćŠw•”ŒŒ‰t“ą‰Č), ‹v•Ū•¶m, Š_‰Ō˜a•F, ’–Žė‹œ, •{“N–ē, •Ÿ“c“N–ē, Vˆä•¶Žq, ŽO–Ų“O, ŽO‰YC@—Տ°ŒŒ‰t(0485-1439)47ŠŖ9† Page1192(2006.09)
  38. ŲœĒ—į‚̉šĶ‚É‚ę‚é”ńB”ńCŠĢ×–EŠą‚ʐ¶ŠˆKе•a‚Ø‚ę‚Ń”ńƒAƒ‹ƒR[ƒ‹«Ž‰–b«ŠĢ޾г‚Ę‚ĢŠÖ˜A«(‰ļ‹c˜^)@‚¼“Ā(ĀŽR•a‰@(‹¤Ļ) ŠO‰Č), –ģŒū“T’j, ’–Žė‹œ, H“”“Ä, •ģ•qŗ, ’†‘ŗ“T–¾, “c’†^“ń, ģ‘ŗ“O, Ž›–{Œ¤ˆź, —LˆäŽ Ž÷@ŠĢ‘Ÿ(0451-4203)47ŠŖSuppl.1 PageA198(2006.04)
  39. V‚µ‚¢Gleason Grading‚ÉŠī‚Ć‚¢‚½‘O—§‘B•a—ƒAƒgƒ‰ƒX‚Ģģ¬‚Ę‘O—§‘B•a—Œ¤C‚ĢŽŽ‚Ż(‰ļ‹c˜^)@‰Ŗ“c—m•½(‘‰ĮŽs—§•a‰@ ”å”AŠķ‰Č), Š™“c¬–F, –ŲŒ“˜a“æ, ¬’r·—Y, ’–Žė‹œ@“ś–{”å”AŠķ‰ČŠw‰ļŽGŽ(0021-5287)97ŠŖ2† Page464(2006.03)
  40. ‘qŽm, ‘å’J‹`•v, ”’ą_—“‘¾˜Y, ‰Ķ“ą—m, ‘åźŠx•F, ŒĆ‰Ę³, ‹Ź‰Ŗ–¾—m, m‘½“Š•F, ˆéŠLi, ‹{č‘א¬, •‘ŗ–ÆŽq, ˆī£’¼•F, ‹gąV–õ”V@–«‰ß•q«‡•¹”xŠą,äPŒ“•a”x‡•¹”xŠą‚Ģ—Õ°•a—Šw“IŒŸ“¢@‘ę47‰ń“ś–{”xŠąŠw‰ļ‘‰ļ@2006”N12ŒŽC‹ž“s
  41. ŒE“c“O, z–KG˜a, ŽR–{°”ü, ’·“crˆź, ‚‹““O–ē, ’·–x—D, ¬”ö–F˜Y, ˆ¢•”“N•v, ‰Ķ“ą—m, ’†‘ŗ‹±ˆź@”r•֍¢“ļ‚šŽå‘i‚Ę‚µ‚½’¼’°‹‘åGIST‚Ģ1—į@‘ę68‰ń“ś–{—Տ°ŠO‰ČŠw‰ļ‘‰ļ2006”N11ŒŽCL“‡
  42. ‰Ķ“ą—m, ¬—ѐ^‹G, ‘źąV“oˆź˜Y@G•½ć”ē“ąŽīį‡/ć”ē“ąŠą@f’f‚̐i•ą H“¹ć”ē“ąŠą‚ĘˆŁŒ`¬‚̐f’f‚ĘŽ”—Ɓ@‘ę44‰ń“ś–{ŠąŽ”—ĆŠw‰ļŠwpW‰ļ 2006”N10ŒŽC“Œ‹ž
  43. —Ž‡‚“æ, Ä“”ˆ¤‹L, Ä“”’BĘ, ¬—ѐ^‹G, ‰Ķ“ą—m, •“”i, ”ĀˆäŗŽq, ‹›“cT, ŽR–{’¼Ž÷, “c’†^“ń, —LˆäŽ Ž÷, ŽR‰ŖøŽi@IKKƒĄ—}§‚É‚ę‚éäXŠą‘B—}§Œų‰Ź@‘ę65‰ń“ś–{ŠąŠw‰ļŠwp‘‰ļ 2006”N9ŒŽC‰”•l
  44. ¬—ѐ^‹G, ‰Ķ“ą—m, ‘źąV“oˆź˜Y, “ą“c‰Ą‰ī, ’·’Jģ^‹I, ’r“c‘, –kģ¹L, ]Ī‹`M, ¬’r·—Y@H“¹G•½ć”ēŠą‚ɂ؂ƂéChk2”­Œ»‚ĢŒŸ“¢@‘ę65‰ń“ś–{ŠąŠw‰ļŠwp‘‰ļ 2006”N9ŒŽC‰”•l
  45. ŠÖ‹Ms, ‰Ķ“ą—m, ˆÉ“”‰hģ, –xŒūTˆź˜Y, ‘D“cMŒ°, ‘źąV“oˆź˜Y@‘gDŒ^‚Ø‚ę‚ŃŒ`Žæ”­Œ»‚Ģ“_‚©‚ēŒŸ“¢‚µ‚½ˆŻ•Ŗ‰»Œ^‘BŠą‚Ģˆ««“x@‘ę65‰ń“ś–{ŠąŠw‰ļŠwp‘‰ļ 2006”N9ŒŽC‰”•l
  46. ‰Ķ“ą—mCŠÖ‹MsC“’‘ņ”ü‹IC¬—ѐ^‹GC‘źąV“oˆź˜YC¬’r·—Y@SM‘å’°Šą‚ɂ؂Ƃ郊ƒ“ƒpß“]ˆŚƒŠƒXƒNƒtƒ@ƒNƒ^[‚ĢŒŸ“¢@‘ę17‰ńĮ‰»ŠķŠą”­¶Šw‰ļ‘‰ļ@2006”N9ŒŽC–¼ŒĆ‰®
  47. ¬—ѐ^‹GC‰Ķ“ą—mC‘źąV“oˆź˜YC“ą“c‰Ą‰īC’·’Jģ^‹IC’r“c‘C–kģ¹LC]Ī‹`MH“¹G•½ć”ēŠą‚ɂ؂ƂéChk2”­Œ»‚ĢŒŸ“¢@‘ę17‰ńĮ‰»ŠķŠą”­¶Šw‰ļ‘‰ļ@2006”N9ŒŽC–¼ŒĆ‰®
  48. ŠÖ‹MsC‰Ķ“ą—mCˆÉ“”‰hģC–xŒūTˆź˜YC‘D“cMŒ°C‘źąV“oˆź˜Y@Œ`Žæ”­Œ»‚Ø‚ę‚Ń‘gDŒ^‚Ģ“_‚©‚ēŒŸ“¢‚µ‚½ˆŻ•Ŗ‰»Œ^‘BŠą‚Ģˆ««“x@‘ę17‰ńĮ‰»ŠķŠą”­¶Šw‰ļ‘‰ļ@2006”N9ŒŽC–¼ŒĆ‰®
  49. ‘q“c²Žq, ŽR–{ē²Žq, ‹v•Ū“cˆź“æ, ’·“ąF”V, ŒKŽR—²Žu, ‰Ķ“ą—m, ˆÉ“”‰hģ, ŒÜ–”’¼Ę@“ū“Ŗ•Ŗ”傚Žå‘i‚Ę‚µ‚½üˆŪ‘BŽī‚Ģ“ń—į@‘ę14‰ń“ś–{“ūŠąŠw‰ļ‘‰ļ@2006”N5ŒŽC‹ą‘ņ
  50. ŒKŽR—²Žu, ’·“ąF”V, ’¹‰®—mˆź, —L‰ź’q”V, —Ń—S“ń, ’†ģ„Žm, ‹v•Ū“cˆź“æ, ‰Ķ“ą—m, ˆÉ“”‰hģ, ™Œ“Œ’ˆź    “ūŠą‚ɂ؂ƂéapoptosisŠÖ˜Aˆā“`Žq‚Ģƒƒ`ƒ‹‰»@‘ę14‰ń“ś–{“ūŠąŠw‰ļ‘‰ļ@2006”N5ŒŽC‹ą‘ņ
  51. ’¹‰®—mˆź, ’·“ąF”V, ŒKŽR—²Žu, —Ń—S“ń, ‹v•Ū“cˆź“æ, ‰Ķ“ą—m, ˆÉ“”‰hģ, —L‰ź’q”V, ™Œ“Œ’ˆź@“ūŠąp‘O‰»Šw—Ć–@‚ɂ؂ƂéEC followed by docetaxel‚ĘFEC followed by docetaxel‚Ƃ̔äŠrŒŸ“¢@‘ę14‰ń“ś–{“ūŠąŠw‰ļ‘‰ļ@2006”N5ŒŽC‹ą‘ņ
  52. ‘qŽm, ‘å’J‹`•v, ‰Ķ“ą—m, ¬ŽRM”V, ˆéŠLi, ‹{č‘א¬, ‰Pˆä—T, ˆī£’¼•F, •‘ŗ–ÆŽq, ‹gąV–õ”V@”xŠą‡•¹–«‰ß•q«”x‰Š‚Ģ—Õ°“IŒŸ“¢@‘ę46‰ń“ś–{ŒÄ‹zŠķŠw‰ļŠwpu‰‰‰ļ@2006”N6ŒŽC“Œ‹ž
  53. ģ“cŒ¤˜Y, ‰Ķ–ģ’CK, ŠÖ“c‹g‹v, ¬“ˆˆźK, ‰iˆäŠÓ, ¼ˆü“O˜Y, ’†“‡NW, ‰¬’Jˆź’j, “ŒŠC—Ń—T, ‰Ķ“ą—m@“ÆŽž«ˆŁŽž«d•”Šą‚ĢŠO‰ČŽ”—Ɓ@H“¹Šą“ÆŽž«ˆŁŽž«Šą‚ĢŠO‰ČŽ”—Ć-ˆŻŠĒŠą‚𒆐S‚Ę‚µ‚½ŒŸ“¢@‘ę61‰ń“ś–{Į‰»ŠķŠO‰ČŠw‰ļ‘‰ļ@2006”N7ŒŽC‰”•l
  54. –xŒūTˆź˜Y, ”䓇P˜a, —эKŽq, ‰Ķ“ą—m, ˆÉ“ŒŠ±é, Ŗ–{“N¶, āŒ³ˆź—t, ‚ŒKN¬, œA‰ŖMˆź, –xŒū˜a”ü, ²Ž”dt, ŒĖˆä‰ė˜a, ‘D“cMŒ°@“ū‘BƒZƒ“ƒ`ƒlƒ‹ƒŠƒ“ƒpß¶ŒŸ‚̐v‘¬•a—ŒŸõ•ū–@‚ɂ‚¢‚Ä‚ĢŒŸ“¢@‘ę95‰ń“ś–{•a—Šw‰ļ‘‰ļ@2006”N4ŒŽC“Œ‹ž
  55. ‹v•Ū“cˆź“æ, ŒÜ–”’¼Ę, ‘q“c²Žq, ŽR–{ē²Žq, ’·“ą—²”V, —L‰ź’q”V, ŒKŽR—²Žu, —Ń—T“ń, ‰Ķ“ą—m, a’J‹Ļ@“ūŠąp‘O•ā•‰»Šw—Ć–@‚ɂ؂ƂéMRI‰ę‘œŠŒ©‚̕ω»‚ĢŒŸ“¢@‘ę65‰ń“ś–{ˆćŠw•śŽĖüŠw‰ļ‘‰ļ@2006”N4ŒŽC‰”•l
  56. ‰Ķ“ą—mCŠÖ‹MsCˆÉ“”‰hģC‰Ķ–ģ’CKC–xŒūTˆź˜YCŠāč‘P‹BCrˆä–M‰ĄC‹g“c’B–ēC]Ī‹`MC‘źąV“oˆź˜YC¬’r·—Y@ˆŻSMŠą‚Ģ‘gDŒ^‚É’…–Ś‚µ‚½ƒŠƒ“ƒpß“]ˆŚŠėŒÆ“x‚ĢŒŸ“¢\“ąŽ‹‹¾Ž”—Â̓K‰žŠg‘å‚̉”\«\@‘ę78‰ń“ś–{ˆŻŠąŠw‰ļ‘‰ļ@2006”N3ŒŽC‘åć
  57. ŠÖ‹MsC‰Ķ“ą—mCˆÉ“”‰hģC–xŒūTˆź˜YC‘źąV“oˆź˜Y@ˆŻ“ū“Ŗó‘BŠą‚ĘŠĒó‘BŠą‚Ģˆ««“x‹y‚Ń”­ŠąŒo˜H‚Ģ•a—Šw“IŒŸ“¢@‘ę78‰ń“ś–{ˆŻŠąŠw‰ļ‘‰ļ@2006”N3ŒŽC‘åć
  58. ˆÉ“”‰hģC‰Ķ“ą—mC’–Žė‹œ, ŠÖ‹Ms, –¾ĪI, ]Ī‹`M, ‘źąV“oˆź˜Y, ¬’r·—Y, ‰Ķ–ģ’CKˆŻŒ`Žæ×–EŽīMP—Ć–@Œć‚ĢŒo‰ßŠĻŽ@’†‚ɐ¶‚¶‚½AL”Ķ‚ČŠg‚Ŗ‚č‚šŽ¦‚·‘ŠśŠą‚Ģˆź—į@‘ę78‰ń“ś–{ˆŻŠąŠw‰ļ‘‰ļ@2006”N3ŒŽC‘åć
  59. ’ĆŒ˜”ü‹MŽq, ¬—Ń‘å•ć, ]Ī‹`M, ¬’r·—Y@—‘‘ƒ–¾×–EŠą‚Ø‚ę‚ŃŽq‹{“ą–ŒĒ‚ɂ؂ƂéHepatocyte nuclear factor-1 beta”­Œ»‚̖Ɖu‘gD‰»Šw“IŒŸ“¢(‰ļ‹c˜^)@“ś–{•a—Šw‰ļ‰ļŽ(0300-9181)95ŠŖ1† Page294(2006.04)
  60. •½ˆärs, ¬—Ń‘å•ć, ’r“c‘, ]Ī‹`M, ¬’r·—Y@Glioma‚ɂ؂Ƃé1p‚Ø‚ę‚Ń19qŒ‡‘¹‚Ģ—L–³‚ĘŒ`‘ŌŠw“IŠŒ©‚Ģ”äŠr(‰ļ‹c˜^)@“ś–{•a—Šw‰ļ‰ļŽ(0300-9181)95ŠŖ1† Page389(2006.04)
  61. •Ÿ“c«‹`, ķ[‘׎i, ŌĄŽĄ•ä, —ZO‘¾, ŽOžŠL•v, ‰”“c—²“æ, …ąV‰p—m, ˜e–{_–¾, •{“N–ē, ¬—Ń‘å•ć@¶ŽO³_Œo’ɂɂĔ­Ē‚µ‚½’†•_ŒoŒnŒ“”­ˆ««ƒŠƒ“ƒpŽī‚Ģ1—į(‰ļ‹c˜^)@“ś–{“ą‰ČŠw‰ļŠÖ“Œ’n•ū‰ļ(‰‰‘č—vŽ|) Page18(2006.07)
  62. Œ©‚ŒbŽqA‹Ź‹“‚¤‚ē‚ēA¬ŽRM”VA‹{č‘א¬A‘å’J‹`•vAˆī£’¼•FA‚‹“˜a‹vAŒFā—˜•vAÖ–Ų–ĪŽ÷A‹gąV–õ”V@‹CŠĒŽxŠg’£‘œ‚Ę”x‹CŽī‘œ‚𔺂Į‚½‡UaŒ^UsherĒŒóŒQ‹^‚¢ŒZ’ķ—į@‘ę46‰ń“ś–{ŒÄ‹zŠķŠw‰ļŠwp‘‰ļ@2006”N6ŒŽ@“Œ‹ž
  63. “c’†“¹—Y, ķ[‚ ‚«‚³, ‹Ź‹“‚¤‚ē‚ē, ]čs–FF‹×–E‚ĢoŒ»‚𔺂¤Œ€ĒŒ^S‹Ų‰Š‚Ģ1–UŒŸ—įAzŠĀŠķ‰Č59ŠŖ3† Page307(2006.03
yŒ¤‹†•¬‹ąz
  1. ]Ī‹`MF•½¬18”N“x‰ČŠwŒ¤‹†”ļ•ā•‹ąAŠī”ÕŒ¤‹†i‚ajƒI[ƒgƒtƒ@ƒW[‚É‚ę‚é×–E“ąŠ“õ–hŒäƒVƒXƒeƒ€‚Ę“÷‰čŽīŒ`¬‹@\iŒ¤‹†‘ć•\ŽŅj
  2. ]Ī‹`MF•½¬18”N“xŒś¶˜J“­‰ČŠwŒ¤‹†”ļ•ā•‹ąi“ļŽ”«Ž¾Š³Ž•žŒ¤‹†Ž–‹Ęj‚т܂ń«”x޾г’²øŒ¤‹†”ǁi•Ŗ’SŒ¤‹†ŽŅj
  3. ¬—Ń‘å•ćF•¶•”‰ČŠwČ@‰ČŒ¤”ļ@ŽįŽč@Œ¤‹†”Ō†F16790203

j